348 related articles for article (PubMed ID: 15327541)
1. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
[TBL] [Abstract][Full Text] [Related]
2. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
3. Confirmation of a disease model of pemphigus vulgaris: characterization and correlation between disease parameters in 90 mice.
Holm TL; Markholst H
Exp Dermatol; 2010 Aug; 19(8):e158-65. PubMed ID: 20201956
[TBL] [Abstract][Full Text] [Related]
4. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus.
Amagai M; Tsunoda K; Suzuki H; Nishifuji K; Koyasu S; Nishikawa T
J Clin Invest; 2000 Mar; 105(5):625-31. PubMed ID: 10712434
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
[TBL] [Abstract][Full Text] [Related]
7. Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris.
Yokoyama T; Matsuda S; Takae Y; Wada N; Nishikawa T; Amagai M; Koyasu S
Int Immunol; 2011 Jun; 23(6):365-73. PubMed ID: 21525154
[TBL] [Abstract][Full Text] [Related]
8. Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model.
Aoki-Ota M; Kinoshita M; Ota T; Tsunoda K; Iwasaki T; Tanaka S; Koyasu S; Nishikawa T; Amagai M
J Invest Dermatol; 2006 Jan; 126(1):105-13. PubMed ID: 16417225
[TBL] [Abstract][Full Text] [Related]
9. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.
Kawasaki H; Tsunoda K; Hata T; Ishii K; Yamada T; Amagai M
J Invest Dermatol; 2006 Dec; 126(12):2621-30. PubMed ID: 16841036
[TBL] [Abstract][Full Text] [Related]
10. Pemphigus vulgaris and its active disease mouse model.
Amagai M
Curr Dir Autoimmun; 2008; 10():167-81. PubMed ID: 18460885
[TBL] [Abstract][Full Text] [Related]
11. Aire-dependent thymic expression of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance.
Wada N; Nishifuji K; Yamada T; Kudoh J; Shimizu N; Matsumoto M; Peltonen L; Nagafuchi S; Amagai M
J Invest Dermatol; 2011 Feb; 131(2):410-7. PubMed ID: 21048786
[TBL] [Abstract][Full Text] [Related]
12. Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance.
Ota T; Aoki-Ota M; Tsunoda K; Nishikawa T; Koyasu S; Amagai M
Int Immunol; 2008 Oct; 20(10):1351-60. PubMed ID: 18765425
[TBL] [Abstract][Full Text] [Related]
13. Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies.
Takae Y; Nishikawa T; Amagai M
Exp Dermatol; 2009 Mar; 18(3):252-60. PubMed ID: 18643850
[TBL] [Abstract][Full Text] [Related]
14. A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris.
Takahashi H; Kuwana M; Amagai M
J Immunol; 2009 Feb; 182(3):1740-5. PubMed ID: 19155523
[TBL] [Abstract][Full Text] [Related]
15. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M
J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
[TBL] [Abstract][Full Text] [Related]
17. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
20. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H
J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
